Literature DB >> 13712596

Comparative effects of beta-propiolactone on mice, mouse-derived cell cultures, and Venezuelan equine encephalomyelitis virus.

H J HEARN, F W DAWSON.   

Abstract

Studies were made comparing the toxicity of beta-propiolactone (BPL) for mammalian (mouse) cells in vitro and for mice and for Venezuelan equine encephalomyelitis (VEE) virus which is highly cytopathogenic for each. The mammalian cells grown in tissue culture were found to be adversely affected by BPL in concentrations ranging from 0.001 to 0.1 mg/ml of supernatant fluid. The difference in response was influenced by the menstruum in which the BPL was suspended and the difference in cell types tested. Tenfold less BPL appeared to be required to destroy the cells when it was suspended in a balanced salt solution than when it was suspended in protein-containing solutions such as beef heart infusion broth or medium 199 plus 20% horse serum. Secondary embryonic mouse lung cells seemed slightly more adversely affected by BPL than the established embryonic lung or L cells. BPL given to mice by intranasal instillation and by intracerebral injection was lethal to half of the animals within 2 days at doses of 0.31 and 0.39 mg, respectively. Higher concentrations of BPL were required to rapidly inactivate the virus in vitro than were required to kill mice or to cause a toxic effect on cells in culture. It required 10 mg/ml of BPL to completely inactivate a high-titered VEE virus preparation in 5 min and 1 mg/ml to inactivate most, but not all, of the virus in 15 min. A concentration of 0.1 mg/ml of BPL had only a slight effect on the virus after a period as long as 60 min. Evidence is presented indicating that simultaneous inactivation of all of the properties of the VEE virus particles by BPL aerosols did not occur at the same time but that, after treatment, the virus possessed a limited ability to immunize mice despite a loss in infectivity.

Entities:  

Keywords:  ENCEPHALOMYELITIS, EQUINE/virology; LACTONES/pharmacology; TISSUE CULTURE/pharmacology; VIRUSES/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 13712596      PMCID: PMC1057725          DOI: 10.1128/am.9.4.278-282.1961

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  Method for disinfecting large enclosures with beta-propiolactone vapor.

Authors:  D R SPINER; R K HOFFMAN
Journal:  Appl Microbiol       Date:  1960-05

2.  Virucidal activity of beta-propiolactone vapor. I. Effect of beta-propiolactone vapor on Venezuelan equine encephalomyelitis virus.

Authors:  F W DAWSON; H J HEARN; R K HOFFMAN
Journal:  Appl Microbiol       Date:  1959-07

3.  The toxic activity of vaccinia virus in tissue culture.

Authors:  A BROWN; S A MAYYASI; J E OFFICER
Journal:  J Infect Dis       Date:  1959 Mar-Apr       Impact factor: 5.226

4.  Virucidal activity of beta-propiolactone vapor. II. Effect on the etiological agents of smallpox, yellow fever, psittacosis, and Q fever.

Authors:  F W DAWSON; R J JANSSEN; R K HOFFMAN
Journal:  Appl Microbiol       Date:  1960-01

5.  Investigations of the use of beta-propiolactone in virus inactivation.

Authors:  G A LOGRIPPO
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

6.  A variant of Venezuelan equine encephalomyelitis virus attenuated for mice and monkeys.

Authors:  H J HEARN
Journal:  J Immunol       Date:  1960-06       Impact factor: 5.422

7.  Betapropiolactone vapor as a disinfectant.

Authors:  R K HOFFMAN; B WARSHOWSKY
Journal:  Appl Microbiol       Date:  1958-09

8.  Nutrition of animal cells in tissue culture; initial studies on a synthetic medium.

Authors:  J F MORGAN; H J MORTON; R C PARKER
Journal:  Proc Soc Exp Biol Med       Date:  1950-01
  8 in total
  2 in total

1.  Epidemiological aspects of venezuelan equine encephalitis virus infections.

Authors:  R W Sidwell; L P Gebhardt; B D Thorpe
Journal:  Bacteriol Rev       Date:  1967-03

2.  Development of an algorithm for production of inactivated arbovirus antigens in cell culture.

Authors:  C H Goodman; B J Russell; J O Velez; J J Laven; W L Nicholson; D A Bagarozzi; J L Moon; K Bedi; B W Johnson
Journal:  J Virol Methods       Date:  2014-08-04       Impact factor: 2.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.